OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 102937-102937
Open Access | Times Cited: 12
Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 102937-102937
Open Access | Times Cited: 12
Showing 12 citing articles:
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 683
Open Access | Times Cited: 14
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 683
Open Access | Times Cited: 14
Durability of immune responses to SARS-CoV-2 infection and vaccination
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
Gagandeep Singh, Anass Abbad, Johnstone Tcheou, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 564-575
Open Access | Times Cited: 9
Gagandeep Singh, Anass Abbad, Johnstone Tcheou, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 564-575
Open Access | Times Cited: 9
Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population
Renée Bazin, Samuel Rochette, Josée Perreault, et al.
Infectious Diseases (2023) Vol. 55, Iss. 6, pp. 425-430
Closed Access | Times Cited: 7
Renée Bazin, Samuel Rochette, Josée Perreault, et al.
Infectious Diseases (2023) Vol. 55, Iss. 6, pp. 425-430
Closed Access | Times Cited: 7
Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria
Martin Riesenhuber, Christian Nitsche, Christoph J. Binder, et al.
BMJ Open (2023) Vol. 13, Iss. 1, pp. e063760-e063760
Open Access | Times Cited: 5
Martin Riesenhuber, Christian Nitsche, Christoph J. Binder, et al.
BMJ Open (2023) Vol. 13, Iss. 1, pp. e063760-e063760
Open Access | Times Cited: 5
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
John Kubale, Charles Gleason, Juan Manuel Carreño, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 9
John Kubale, Charles Gleason, Juan Manuel Carreño, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 9
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
SARS-CoV-2 spike-binding antibody longevity and protection from re-infection with antigenically similar SARS-CoV-2 variants
John Kubale, Charles Gleason, Juan Manuel Carreño, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
John Kubale, Charles Gleason, Juan Manuel Carreño, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population
Renée Bazin, Samuel Rochette, Josée Perreault, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Renée Bazin, Samuel Rochette, Josée Perreault, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Comparison of nucleocapsid and spike antibody ELISAs for determining SARS‐CoV‐2 seropositivity in Kenyan women and infants
Carolyn S. Fish, Prestone Owiti, Emily R. Begnel, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 2
Carolyn S. Fish, Prestone Owiti, Emily R. Begnel, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 2
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
